Fractional flow reserve versus intravascular imaging to guide decision‐making for percutaneous coronary intervention in intermediate lesions: A meta‐analysis
Catheterization and Cardiovascular Interventions · 2023
DOI: 10.1002/ccd.30909 ↗At a glance
Systematische Übersicht in Catheterization and Cardiovascular Interventions, 2023. Written by Xiaochen Liu and 6 co-authors. Institution: Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Major MEDLINE topics: Fractional Flow Reserve, Myocardial, Percutaneous Coronary Intervention, Coronary Artery Disease. Cited 5 times so far (Crossref); 47 references. Funded by: National Key R&D Program of China, Natural Science Foundation of Beijing, China, Interdisciplinary Cooperation Project of Beijing Nova Program.
Abstract (original language)
Background
Both fractional flow reserve (FFR) and intravascular imaging (IVI) have been used to guide the decision‐making for percutaneous coronary intervention (PCI) in intermediate coronary stenosis. Nevertheless, studies that directly compared the prognostic significance of these two strategies are scarce.
Aims
The aim of this meta‐analyses was to evaluate the impact of FFR versus IVI to guide the decision‐making in PCI for intermediate stenosis on clinical outcomes.
Methods
We systematically searched PubMed, Embase, Cochrane, and relevant database from inception date to September 2022 for observational studies and randomized clinical trials (RCTs) which compared FFR and IVI‐based decision‐making in PCI for intermediate stenosis. The primary outcome was a composite of major adverse cardiac event (MACE). Pooled risk ratios (RR) were calculated using random effects models and heterogeneity were evaluated with the I 2 statistic.
Results
We identified 5 studies (3 RCTs and 2 observational studies) with 3208 patients. The follow‐up duration ranged from 12 to 24 months. Among five studies, four compared FFR with intravascular ultrasound while one compared FFR with optical coherence tomography. There was no statistically difference between FFR and IVI in the incidence of MACE (RR: 1.19; 95% confidence interval: 0.85–1.68; p = 0.31) and its individual components. These results were consistent regardless of various cut‐off value of PCI across the studies. Compared with IVI, FFR was associated with a lower PCI rate (37.0% vs. 60.3%; p < 0.001).
Conclusions
The decision to perform PCI for intermediate stenosis guided by FFR or IVI showed a similar clinical outcome. The use of FFR significantly reduced the need for PCI.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Center for Coronary Artery Disease, Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- Cardiovascular Research Foundation, New York, New York, USA.
Funding
- National Key R&D Program of China
- Natural Science Foundation of Beijing, China
- Interdisciplinary Cooperation Project of Beijing Nova Program
- Beijing Nova Program
Cite
APA
Liu, X., Zhang, Y., Xu, Y., Tang, Z., Wang, X., Nie, S., & Mintz, G. S. (2023). Fractional flow reserve versus intravascular imaging to guide decision‐making for percutaneous coronary intervention in intermediate lesions: A meta‐analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30909
Vancouver
Liu X, Zhang Y, Xu Y, Tang Z, Wang X, Nie S, et al. Fractional flow reserve versus intravascular imaging to guide decision‐making for percutaneous coronary intervention in intermediate lesions: A meta‐analysis. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30909
BibTeX
@article{Liu2023,
author = {Liu, Xiaochen and Zhang, Yushi and Xu, Yang and Tang, Zhe and Wang, Xiao and Nie, Shaoping and Mintz, Gary S},
title = {Fractional flow reserve versus intravascular imaging to guide decision‐making for percutaneous coronary intervention in intermediate lesions: A meta‐analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
doi = {10.1002/ccd.30909}
}
EUVIMED